Cargando...
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
Drug-induced interstitial lung disease (DI-ILD) is a rare, yet life-threatening complication associated with tyrosine-kinase inhibitor (TKI) therapy. Third-generation epidermal growth factor receptor-TKI, osimertinib use can be associated with a benign radiological finding called transient asymptoma...
Guardado en:
| Publicado en: | Case Rep Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger AG
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216030/ https://ncbi.nlm.nih.gov/pubmed/34177523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000516274 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|